- August 24, 2016
Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease
- August 15, 2016
Harvard licenses powerful molecular screening platform to Kyulux, developer of OLED display technologies
- March 21, 2016
Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.
- December 23, 2015
UCB-funded Harvard study describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
- September 16, 2014
Professors Dan Finley and Randy King are poised to change the future for those who suffer from neurodegenerative diseases. With the help of OTD’s Biomedical Accelerator, they were able to build on this foundation and advance the frontiers of science and healthcare.